Is 300314 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 300314 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 300314 (CN¥11.82) is trading above our estimate of fair value (CN¥0.35)
Significantly Below Fair Value: 300314 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 300314?
Key metric: As 300314 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for 300314. This is calculated by dividing 300314's market cap by their current
earnings.
What is 300314's PE Ratio?
PE Ratio
38.6x
Earnings
CN¥88.12m
Market Cap
CN¥3.40b
300314 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: 300314 is expensive based on its Price-To-Earnings Ratio (38.6x) compared to the CN Medical Equipment industry average (35.2x).
Price to Earnings Ratio vs Fair Ratio
What is 300314's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
300314 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
38.6x
Fair PE Ratio
37.5x
Price-To-Earnings vs Fair Ratio: 300314 is expensive based on its Price-To-Earnings Ratio (38.6x) compared to the estimated Fair Price-To-Earnings Ratio (37.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.